MARTINGALE ASSET MANAGEMENT L P
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 936944
BOSTON, MA
Position in INDV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,240,072
New position
Shares Held
139,110
first reported quarter
Ownership
0.114%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 39.54424556106678.ToString("F0")%
Shared 0.ToString("F0")%
None 60.45575443893322.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARTINGALE ASSET MANAGEMENT L P holds $47,192,066 across 16 Drug Manufacturers - Specialty & Generic names. INDV ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
194,766 | $6,886,925 | |
| 2 | ZTS |
Zoetis Inc.
|
49,722 | $5,877,637 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
41,023 | $5,404,370 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,491 | $4,442,013 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
139,110 | $4,240,072 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
67,548 | $3,491,556 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
260,311 | $3,235,665 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
51,039 | $3,025,081 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,240,072 | 139,110 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||